Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1121-7. doi: 10.1111/jdv.12762. Epub 2014 Oct 7.
Depigmentation therapy can be an option in adults with extensive and refractory vitiligo. Remaining pigmented patches can be removed using depigmentation creams (monobenzyl ether of hydroquinone 20%), laser therapy or cryotherapy. In contrast to cream treatment, laser therapy and cryotherapy are fast and targeted methods, capable of destroying melanocytes selectively on one specific area. Up till now, controlled trials comparing laser and cryotherapy as depigmenting treatment in vitiligo are lacking.
We performed a retrospective comparative study in 22 generalized vitiligo patients. Thirty-one pigmented test regions were exposed to cryotherapy and 20 to 755 nm laser therapy. The mean surface area per test region was 3.55 cm2 and number of treatments per test region was limited to one single session in 84.3% and varied up to four sessions (2.0%).
Overall no significant difference in the capacity to induce depigmentations was observed between cryotherapy (46.7%) and laser therapy (42.9%) after one treatment. The percentage of induced depigmentation was significantly different according to the body location (P = 0.005) with best results on the trunk, followed by the arms, face, neck and less on the hands. Variables that positively influenced depigmentation results were a younger age of vitiligo onset (P = 0.012), skin type V (P < 0.001) and clinical presence of Koebner's phenomenon (P = 0.039). Despite initial failure after one treatment, repetitive treatment sessions on eight test areas resulted in successful depigmentation. Side-effects were restricted to cryotherapy and concerned mainly hyperpigmentation in the face.
To our knowledge, this is the first study comparing head-to-head depigmentation strategies intra- and inter-individually. We could demonstrate that in general laser and cryotherapy are equally effective in inducing depigmentations in generalized vitiligo patients. Retreatment of the same area may be required in case of initial failure.
脱色疗法可作为广泛且难治性白癜风成人患者的选择。剩余的色素斑可以使用脱色霜(对苯二酚单苄醚 20%)、激光疗法或冷冻疗法去除。与乳膏治疗相比,激光疗法和冷冻疗法是快速且针对性的方法,能够在一个特定区域选择性地破坏黑素细胞。到目前为止,比较激光和冷冻疗法作为白癜风脱色治疗的对照试验尚缺乏。
我们对 22 例泛发性白癜风患者进行了回顾性比较研究。31 个色素斑试验区接受冷冻治疗,20 至 755nm 激光治疗。每个试验区的平均表面积为 3.55cm2,每个试验区的治疗次数限制为一次,84.3%的试验区为单次治疗,最多为 4 次(2.0%)。
单次治疗后,冷冻治疗(46.7%)和激光治疗(42.9%)在诱导脱色方面总体无显著差异。诱导脱色的百分比根据身体部位(P=0.005)有显著差异,躯干效果最好,其次是手臂、面部、颈部,手部效果较差。影响脱色效果的变量有白癜风发病年龄较轻(P=0.012)、皮肤类型 V(P<0.001)和临床存在科布纳现象(P=0.039)。尽管单次治疗后最初失败,但对 8 个试验区进行重复治疗后,成功实现了脱色。副作用仅限于冷冻治疗,主要涉及面部色素沉着过度。
据我们所知,这是首次在个体内和个体间比较头对头的脱色策略的研究。我们可以证明,在一般情况下,激光和冷冻疗法在诱导泛发性白癜风患者脱色方面同样有效。如果初始治疗失败,可能需要对同一区域进行重复治疗。